title: Parkinsonism as a side effect of infliximab.
abstract: We present a case of a 64-year-old man with Crohn's disease who developed parkinsonism after starting treatment with infliximab (Remicade). The patient had a 30-year history of Crohn's disease with previous surgical procedures and treatment with methotrexate. Treatment was augmented with infliximab, and 3 days after the first dose of 400 mg, a resting tremor began in the left leg. Over 4 months, symptoms progressed and now involved the right leg as well as both hands. There was no clinical effect of infliximab treatment, and the treatment was withdrawn 4 months later. The patient then experienced gradual, but continual, improvement of the resting tremor after withdrawal of infliximab. To the best of our knowledge, this is the first case report describing a patient developing parkinsonism after starting treatment with infliximab, with symptoms remitting on discontinuation.
authors.affiliation: Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.
authors.forename: Jakob Nørgaard
authors.initials: JN
authors.lastname: Henriksen
authors.affiliation: Department of Neurology, Hospitalsenheden Midt, Viborg, Denmark.
authors.forename: Bengt Oluf Mikael
authors.initials: BO
authors.lastname: Eriksson
mesh_terms: D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000139:chemically induced*
chemical_list: D000069285:Infliximab